Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.

One in eight men will be diagnosed with prostate cancer. It is estimated that in 2023 alone, 288,300 men will be diagnosed with prostate cancer. For those diagnosed, there are several treatment ...

Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...

Among patients who underwent surgery, those who engaged in vigorous physical activity after diagnosis had a significant improvement in disease-free survival. Engaging in vigorous physical activity ...

In 2013, a prostate-specific antigen (PSA) blood test revealed that Richard LaFrate's levels had jumped. Previously in a normal range, LaFrate's PSA was now above 6 ng/mL, indicating an elevated ...

In prostate cancer, hormone therapy is treatment to keep the cancer cells from getting testosterone, the main male hormone (androgen). Hormone therapy for prostate cancer is also called ...

ALTOONA, Pa. (WTAJ) — Cancer patients in Central Pennsylvania now have greater access to an advanced prostate cancer treatment with the launch of Pluvicto at UPMC Altoona. Beginning in April, UPMC ...

In a randomized clinical trial, Mass General Brigham researchers found testosterone replacement therapy also improved quality of life for men who had undergone radical prostatectomy ...